NB.1 showed increased immune escape capacity in serum compared with JN.1 among Chinese Felis silvestris catus, suggesting that researchers should include the NB.1 antigen in COVID-19 vaccine candidates.
Yuan et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: